These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16865725)

  • 1. Clusterin is not essential for androgen-regulated involution and regeneration of the normal mouse prostate.
    Fink D; Fazli L; Aronow B; Gleave ME; Ong CJ
    Prostate; 2006 Sep; 66(13):1445-54. PubMed ID: 16865725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.
    Miyake H; Hara I; Gleave ME
    Int J Urol; 2005 Sep; 12(9):785-94. PubMed ID: 16201973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond simple castration: targeting the molecular basis of treatment resistance in advanced prostate cancer.
    Gleave M; Miyake H; Chi K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():47-57. PubMed ID: 16273354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short-term neoadjuvant hormone therapy enhanced expression of clusterin in prostate cancer].
    Niu YN; Xin DQ; He ZS; Zhou LQ; Pan BN; Na YQ; Guo YL
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):394-7. PubMed ID: 15854351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer.
    Gleave ME; Miyake H; Zellweger T; Chi K; July L; Nelson C; Rennie P
    Urology; 2001 Aug; 58(2 Suppl 1):39-49. PubMed ID: 11502446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knock-down of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancers.
    Gleave M; Chi KN
    Ann N Y Acad Sci; 2005 Nov; 1058():1-15. PubMed ID: 16394121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.
    Gleave M; Miyake H
    World J Urol; 2005 Feb; 23(1):38-46. PubMed ID: 15770517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitro.
    Zhang Q; Zhou W; Kundu S; Jang TL; Yang X; Pins M; Smith N; Jovanovic B; Xin D; Liang L; Guo Y; Lee C
    BJU Int; 2006 Aug; 98(2):452-60. PubMed ID: 16879694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals.
    Hsieh CL; Xie Z; Liu ZY; Green JE; Martin WD; Datta MW; Yeung F; Pan D; Chung LW
    J Mol Endocrinol; 2005 Oct; 35(2):293-304. PubMed ID: 16216910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.
    Ma C; Yoshioka M; Boivin A; Gan L; Takase Y; Labrie F; St-Amand J
    Prostate; 2009 Feb; 69(3):293-316. PubMed ID: 19023869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis.
    Lin Y; Liu G; Zhang Y; Hu YP; Yu K; Lin C; McKeehan K; Xuan JW; Ornitz DM; Shen MM; Greenberg N; McKeehan WL; Wang F
    Development; 2007 Feb; 134(4):723-34. PubMed ID: 17215304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.
    Wu CT; Altuwaijri S; Ricke WA; Huang SP; Yeh S; Zhang C; Niu Y; Tsai MY; Chang C
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12679-84. PubMed ID: 17652515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
    Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME
    Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens.
    Thompson VC; Morris TG; Cochrane DR; Cavanagh J; Wafa LA; Hamilton T; Wang S; Fazli L; Gleave ME; Nelson CC
    Prostate; 2006 Dec; 66(16):1698-709. PubMed ID: 16998820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential age-associated regulation of clusterin expression in prostate lobes of brown Norway rats.
    Omwancha J; Anway MD; Brown TR
    Prostate; 2009 Feb; 69(2):115-25. PubMed ID: 18942093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
    Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
    Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.